Effect of all-trans retinoic acid (ATRA) on syndecan-1 expression and its chemoprotective effect in benzo(α)pyrene-induced lung cancer mice model

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 6, 2012, Pages 1020-1027

  Ramya, D ^a   Siddikuzzaman, ^a   Grace, V M Berlin ^a  

^a KARUNYA UNIVERSITY   (India)

Author keywords

Anti cancer agent; Histopathology; Immunohistochemistry; Lung cancer; Tumor nodule

Indexed keywords

BENZO[A]PYRENE; RETINOIC ACID; SYNDECAN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DRUG RETENTION; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CELL MEMBRANE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; RESPIRATORY MUCOSA; SYNDECAN-1; TRETINOIN;

MUS;

EID: 84868122246     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2012.693086     Document Type: Article

References (53)

1. Yang, J., Lam, E.W., Hammad, H.M., Oberley, T.D., Oberley, L.W. Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium. J Oral Pathol Med 2002, 31, 71-77.
2. Stellman, S.D., Takezaki, T., Wang, L., Chen, Y., Citron, M.L., Djordjevic, M.V., Harlap, S., Muscat, J.E., Neugut, A.I., Wynder, E.L., Ogawa, H., Tajima, K., Aoki, K. Smoking and lung cancer risk in American and Japanese men: an international case-control study. Cancer Epidemiol Biomarkers Prev 2001, 10, 1193-1199.
3. Parkin, D.M., Bray, F., Ferlay, J., Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55, 74-108.
4. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59, 225-249.
5. Hecht, S.S., Upadhyaya, P., Wang, M., Bliss, R.L., McIntee, E.J., Kenney, P.M. Inhibition of lung tumorigenesis in A/J mice byN-acetyl-S-(N-2- phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination. Carcinogenesis 2002, 23, 1455-1461.
6. Sticha, K.R., Staretz, M.E., Wang, M., Liang, H., Kenney, P.M., Hecht, S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse. Carcinogenesis 2000, 21, 1711-1719.
7. Zheng, Y., Kramer, P.M., Lubet, R.A., Steele, V.E., Kelloff, G.J., Pereira, M.A. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 1999, 20, 255-260.
8. Wakino, S., Kintscher, U., Kim, S., Jackson, S., Yin, F., Nagpal, S., Chandraratna, R.A., Hsueh, W.A., Law, R.E. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb Vasc Biol 2001, 21, 746-751.
9. Suzui, M., Masuda, M., Lim, J.T., Albanese, C., Pestell, R.G., Weinstein, I.B. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res 2002, 62, 3997-4006.
10. Crowe, D.L., Kim, R., Chandraratna, R.A. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res 2003, 1, 532-540.
11. Gumireddy, K., Sutton, L.N., Phillips, P.C., Reddy, C.D. All-transretinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin Cancer Res 2003, 9, 4052-4059.
12. Nadauld, L.D., Sandoval, I.T., Chidester, S., Yost, H.J., Jones, D.A. Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation. J Biol Chem 2004, 279, 51581-51589.
13. Siddikuzzaman, Guruvayoorappan C, Berlin Grcae VM. All trans retinoic acid and cancer. Immunopharmacol Immunotoxicol 2011; 33, 241-249.
14. Leder, A., Kuo, A., Cardiff, R.D., Sinn, E., Leder, P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 1990, 87, 9178-9182.
15. Chen, Z.X., Xue, Y.Q., Zhang, R., Tao, R.F., Xia, X.M., Li, C., Wang, W., Zu, W.Y., Yao, X.Z., Ling, B.J. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991, 78, 1413-1419.
16. Lallemand-Breitenbach, V., Guillemin, M.C., Janin, A., Daniel, M.T., Degos, L., Kogan, S.C., Bishop, J.M., de Thu H. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med 1999, 189, 1043-1052.
17. Gamage, S.D., Bischoff, E.D., Burroughs, K.D., Lamph, W.W., Gottardis, M.M., Walker, C.L., Fuchs-Young, R. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma. J Pharmacol Exp Ther 2000, 295, 677-681.
18. Kelly, W.K., Osman, I., Reuter, V.E., Curley, T., Heston, W.D., Nanus, D.M., Scher, H.I. The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. Clin Cancer Res 2000, 6, 838-846.
19. Kumar, A., Soprano, D.R., Parekh, H.K. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res 2001, 61, 7552-7555.
20. Wu, Q., Chen, Z., Su, W. Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression. Chin Med J 2001, 114, 958-961.
21. Chun, K.H., Benbrook, D.M., Berlin, K.D., Hong, W.K., Lotan, R. The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondriadependent pathway. Cancer Res 2003, 63, 3826-3832.
22. Lango, M., Wentzel, A.L., Song, J.I., Xi, S., Johnson, D.E., Lamph, W.W., Miller, L., Grandis, J.R. Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Clin Cancer Res 2003, 9, 4205-4213.
23. Manor, D., Shmidt, E.N., Budhu, A., Flesken-Nikitin, A., Zgola, M., Page, R., Nikitin, A.Y., Noy, N. Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res 2003, 63, 4426-4433.
24. Czeczuga-Semeniuk, E., Anchim, T., Dzieciol, J., Dabrowska, M., Wolczynski, S. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells? Acta Biochim Pol 2004, 51, 733-745.
25. Liu, W.J., Zhang, Y.W., Zhang, Z.X., Ding, J. Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation. J Pharmacol Sci 2004, 96, 106-114.
26. Dahl, A.R., Grossi, I.M., Houchens, D.P., Scovell, L.J., Placke, M.E., Imondi, A.R., Stoner, G.D., De Luca, L.M., Wang, D., Mulshine, J.L. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res 2000, 6, 3015-3024.
27. Chang, Y.S., Chung, J.H., Shin, D.H., Chung, K.Y., Kim, Y.S., Chang, J., Kim, S.K., Kim, S.K. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Yonsei Med J 2004, 45, 435-442.
28. Chansri, N., Kawakami, S., Yamashita, F., Hashida, M. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice. Int J Pharm 2006, 321, 42-49.
29. Tkachenko, E., Rhodes, J.M., Simons, M. Syndecans: new kids on the signaling block. Circ Res 2005, 96, 488-500.
30. Sun, W.P., Wang, F.M., Xie, F., Wang, G.Q., Sun, J., Yu, G.H., Qiu, Y.H., Zhang, X.G. A novel anti-human syndecan-1 (CD138) monoclonal antibody 4B3: characterization and application. Cell Mol Immunol 2007, 4, 209-214.
31. Hirabayashi, K., Numa, F., Suminami, Y., Murakami, A., Murakami, T., Kato, H. Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour Biol 1998, 19, 454-463.
32. Kodama J, Kusumoto T, Shinyo Y, Seki N, Hiramatsu Y. Prognostic significance of syndecan-1 expression in human endometrial cancer. Annals Oncol 2005, 4, 1109-1115.
33. Yang, Y., Macleod, V., Miao, H.Q., Theus, A., Zhan, F., Shaughnessy, J.D. Jr, Sawyer, J., Li, J.P., Zcharia, E., Vlodavsky, I., Sanderson, R.D. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem 2007, 282, 13326-13333.
34. Yan, Y., Wang, Y., Tan, Q., Lubet, R.A., You, M. Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice. Neoplasia 2005, 7, 1053-1057.
35. Suzuki, S., Kawakami, S., Chansri, N., Yamashita, F., Hashida, M. Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes. J Control Release 2006, 116, 58-63.
36. Drabkin DL, Austin JM. Spectrometric studies; spectrometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem 1932, 98, 719-733.
37. Booran GA, Eustis SL, Elwell MR, Montgory CA, McKenzie WF, ed. (1990). Pathology of the Fisher Rat. San Diego: Academic Press, 405Y 418.
38. Wiethege, T., Voss, B., Muler, K.M. P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer. J Cancer Res Clin Oncol 1995, 121, 371-377.
39. Prakash J, Guptha SK, Kochupillai V, Singh N, Gupta YK, Joshi S. Chemopreventive activity of Withania somnifera in experimentally-induced fibrosarcoma tumours in Swiss albino mice. Phytother Res 2000; 14, 1-6.
40. Davis, L., Kuttan, G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 2000, 71, 193-200.
41. Douer, D., Koeffler, H.P. Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. J Clin Invest 1982, 69, 1039-1041.
42. Tobler, A., Dawson, M.I., Koeffler, H.P. Retinoids. Structurefunction relationship in normal and leukemic hematopoiesis in vitro. J Clin Invest 1986, 78, 303-309.
43. Smeland, E.B., Rusten, L., Jacobsen, S.E., Skrede, B., Blomhoff, R., Wang, M.Y., Funderud, S., Kvalheim, G., Blomhoff, H.K. All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells. Blood 1994, 84, 2940-2945.
44. Rusten, L.S., Dybedal, I., Blomhoff, H.K., Blomhoff, R., Smeland, E.B., Jacobsen, S.E. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells. Blood 1996, 87, 1728-1736.
45. Li, S., Yan, T., Yang, J.Q., Oberley, T.D., Oberley, L.W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 2000, 60, 3927-3939.
46. Inki, P., Joensuu, H., Gr?man, R., Klemi, P., Jalkanen, M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 1994, 70, 319-323.
47. Pulkkinen, J.O., Penttinen, M., Jalkanen, M., Klemi, P., Gr?man, R. Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol 1997, 117, 312-315.
48. Iozzo, R.V., Cohen, I. Altered proteoglycan gene expression and the tumor stroma. Experientia 1993, 49, 447-455.
49. Kato, M., Saunders, S., Nguyen, H., Bernfield, M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell 1995, 6, 559-576.
50. Inki, P., Stenb?k, F., Talve, L., Jalkanen, M. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 1991, 139, 1333-1340.
51. Inki, P., Jalkanen, M. The role of syndecan-1 in malignancies. Ann Med 1996, 28, 63-67.
52. Mukunyadzi, P., Liu, K., Hanna, E.Y., Suen, J.Y., Fan, C.Y. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol 2003, 16, 796-801.
53. Bayer-Garner, I.B., Sanderson, R.D., Smoller, B.R. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma. J Cutan Pathol 1999, 26, 386-390.